Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Stockholm, Sweden
Countries of investment
  • Sweden
  • Switzerland
  • Denmark
  • USA
  • Norway
  • Germany
  • France
  • Finland
  • Belgium
  • Canada
  • Ireland
  • United Kingdom
  • Netherlands
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Health Tech
  • Sustainability
  • Biotechnology
  • Digital Health
  • Medical Devices
  • Therapeutics
About
HealthCap is a premier European venture capital firm dedicated to advancing life sciences innovation. Since its inception in 1996, the firm has successfully invested over EUR 1.2 billion in pioneering companies that address significant unmet medical needs and develop transformative therapies. HealthCap's extensive expertise and strategic approach empower entrepreneurs to navigate the complexities of the healthcare landscape, fostering breakthroughs that enhance patient outcomes. With a strong commitment to supporting visionary founders, HealthCap continues to be at the forefront of driving impactful change in the life sciences sector.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

HealthCap invests in life sciences, focusing on diseases with a high unmet medical need and breakthrough therapies that can transform clinical practice and change patients lives.
Lead investor
Co Invest
Number of exits
Preferred contact method

HealthCap Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp